Wednesday, May 28, 2025
Behance Facebook Instagram Linkedin Twitter Vimeo VKontakte Youtube
Home 2024

Yearly Archives: 2024

All News

Adding Quantum Pharmaceutical (QNTM) $4.10 to Reverse Split Stock Watch List.

Editor / Curator -
All News

Cardiol’s (CRDL) Game-Changing Solution for Heart Inflammation? | David Elsley CEO...

Editor / Curator -
2024 Watch List

Nine Page Summary Report on GeoVax (GOVX)

Editor / Curator -
2024 Watch List

GeoVax (GOVX) Provides First Half 2024 Business Update.

Editor / Curator -
All News

Reverse Split Mania! Solgenix (SNGX) Jumps 448% After 1:16.

Editor / Curator -
Biotech News

FDA approves Amgen drug for tough-to-treat form of lung cancer.

Editor / Curator -
2024 Watch List

GeoVax Receives Massive $300+ Million BARDA Project NextGen Award!

Editor / Curator -
2024 Watch List

GeoVax (GOVX) Research Reports Archive

Editor / Curator -
2022 Watch List

Ardelyx (ARDX) Reports First Quarter 2024 Showing $204 Million in Cash!

Editor / Curator -
2024 Watch List

GeoVax to Provide Corporate Update on Tuesday May 14, 2024.

Editor / Curator -
123...6Page 1 of 6

Latest article

Cardiol Therapeutics (CRDL) May 2025 Presentation.

2023 Watch List Editor / Curator -
Click here to open. RELATED: Cardiol’s (CRDL) Game-Changing Solution for Heart Inflammation? | David Elsley CEO – Video Interview

Nice Bounce on Alkaline Water (WTER) up 81%.

All News Editor / Curator -
Well now that ain't bad, up 81%! Our outlook on The Alkaline Water Company, our "comeback of the decade" story, is "let's see what...

Zomedica Corp (ZOMDF) $0.05

Uncategorized Editor / Curator -
Company Overview Background Zomedica Corp., incorporated in 2013 under the Business Corporations Act (Alberta), is headquartered in Ann Arbor, Michigan. Initially listed on the TSX Venture...
The Internet Stock Review is one of Wall Streets oldest newsletters covering internet technology having launched in 1999. The Biotech Stock Review is rather old too, having launched in 2002. We make our money by purchasing stock with our services, so the better our client stocks do, the better we all do. And when we're wrong, we feel the pain too! See our research reports for important disclaimer details. Content is provided by Institutional Analyst Inc., the website is managed by Revelers.IO Media Group Inc. To see if your Company qualifies for coverage, call 310-594-8062
Contact us: roland@institutionalanalyst.com
© Managed by Revelers.IO Media Group Inc.